Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe and Ursodiol in NAFLD
NCT02244944Phase 2Terminated
- Start
- Sep 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ezetimibe, ursodeoxycholic acid in non-alcoholic fatty liver disease (NAFLD). Started Sep 2014; status: terminated.
02
Drugs
ezetimibeursodeoxycholic acid
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02244944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244944.